Synthalis
- Medical device or technology

Synthalis is a medtech innovator developing wearable oxygen modulation technologies. Our flagship product is a patent-pending, air-fed micro electrochemical oxygen concentrator (mEOC) that delivers silent, real-time oxygen enrichment without tanks or compressed gas. Designed for fatigue, sleep disorders, aviation, and emergency use, it offers a non-pharmaceutical alternative to stimulant or sedative therapies. Our class-defining prototypes integrate proprietary PEM and microfluidic engineering. Synthalis holds multiple device patents and is developing an FDA Class II regulatory pathway. We are seeking investors, OEM licensing partners, and academic collaborators, and are exploring U.S. relocation and co-development opportunities.
Address
LondonUnited Kingdom